This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Higher body mass index (BMI) variability is associated with adverse cardiovasculardisease (CVD) events, according to a study published online March 21 in JAMA Network Open.
BackgroundCurrent evidence suggests that cardiovasculardisease (CVD) plays a role in the progression of chronic obstructive pulmonary disease (COPD). However, the relationship between CVD and the severity of COPD remains inadequately understood.
The 2023 Almanac results derived from the Global Burden of Disease (GBD) and spanning 1990 to 2022, were recently published in the Journal of American College of Cardiology. The post Global Trends in CardiovascularDiseases: Insights from the 2023 Almanac appeared first on Cardiology Update. Original article: Mensah GA et al.
BMI variability has been associated with increased cardiovasculardisease risk in individuals with type 2 diabetes, however comparison between clinical studies and real-world observational evidence has been la.
BackgroundObesity is a global epidemic and a major risk factor for cardiovasculardiseases. Laparoscopic sleeve gastrectomy (LSG) is an effective bariatric surgery, but its effect on cardiac functions remains unclear.
Understanding the relationship between serum ferritin levels and cardiovascular outcomes in type 2 diabetes is crucial for improving risk stratification and guiding therapeutic interventions aimed at preventin.
When it comes to cardiovasculardisease, two of the biggest risk factors we must consider are: ApoB concentration - A measure of the number of circulating lipid particles. Excess weight, as measured by BMI, is typically considered a measure of excess body fat. Relationship of BMI and Risk Of Diabetes. But only moderately.
Among patients without diabetes or cardiovasculardisease and with a BMI 27 kg/m2, those with coronary artery calcium (CAC) scoring 300 derive the largest benefit from a weight-loss-dose of semaglutide for the prevention of major adverse cardiovascular events (MACE).
Triglyceride-glucose-BMI (TyG-BMI) index is a surrogate marker of insulin resistance and an important predictor of cardiovasculardisease. However, the predictive value of TyG-BMI index in the progression of n.
The triglyceride glucose-body mass index (TyG-BMI) is recognized as a reliable surrogate for evaluating insulin resistance and an effective predictor of cardiovasculardisease. However, the link between TyG-BM.
According to the 2024 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association , heart disease has been the leading cause of death in the U.S. It’s an honor to have the U.S.’s
The greatest risk for a shortened life expectancy and early onset of diseases arises when you move from pre-diabetes to diabetes. A diagnosis of diabetes pulls forward the time you are likely to develop cardiovasculardisease by a whopping ten years 6. All of these patients had a BMI >27. How To Reverse Diabetes.
Insulin resistance (IR) significantly contributes to cardiovasculardisease (CVD) development. Triglyceride glucose (TyG) index and triglyceride glucose-body mass index (TyG-BMI) are recognised as convenient p.
Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovasculardiseases and thrombotic events. The hemophilia cohort was slightly older (63.2[16.8]
Background Cardiovasculardiseases remain a leading cause of morbidity and mortality worldwide. Accurately predicting the 10-year risk of Atherosclerotic CardiovascularDisease (ASCVD) is crucial for timely intervention and management. ratio (WHT.5R)—were 5R)—were calculated.
Among participants with baseline body mass index (BMI) above 30 kg/m2, 70.4% Eighty percent of heart attacks and strokes are preventable. Yet, CVD remains the leading cause of death in the U.S., reduced their weight within 3 months with a mean reduction of 8.8
as BMI increased by category, and it prevailed more frequently among women and older people regardless of their BMI status. kg/m2), normal weight (18.524 kg/m2), overweight (2428 kg/m2), and obese (>28 kg/m2). The incidence of SMuRFlessness declined from 16.2%
Association between body mass index (BMI) and clinical outcomes in PARADISE-MI. ( A ) Histogram for BMI (kg/m 2 ), ( B ) adverse events for BMI subgroups, and spline model curves for ( C ) the primary composite outcome and ( D ) cardiovascular (CV) death by BMI subgroups. 100 patient-years for BMI 40kg/m 2 ).
In a Global Burden of Disease analysis, the prevalence of obesity was found to have doubled in more than 70 countries from 1980 to 2013. 1 Obesity can adversely affect several health conditions but about two-thirds of deaths attributable to excess body mass index (BMI) are cardiovascular.
There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] These individuals tend to have a better prognosis when compared to both individuals with normal weight (BMI of 18.5
Exercise prevents and reverses cardiovasculardisease, but whether high-intensity exercise training (HIIT) is safe and effective for adults after minimally invasive heart surgery is unknown. Exercise is a wonder drug for cardiovasculardisease (CVD) prevention and reversal. VO2 peak increased by 3.3
They get the diseases of ageing about 20 to 25 years later than everyone else. It’s not that they don’t get cardiovasculardisease, cancer or dementia; they just get it way later than everyone else. Most adults, healthy centenarians included, will die from one of three things: CardiovascularDisease.
However, a series of recent studies in mice and in humans reveals that protein may promote a cascade of events in the body that lead to cardiovasculardisease. All of this is true, yet some observational studies (with all of their inherent flaws) have associated a high (animal) protein intake with cardiovasculardisease risk.
Body mass index (BMI) ‘(weight (kg)/height (m) 2 ) was calculated and patients with BMI ≥30 kg/m 2 were categorised as obese. The mean BMI was 27.48±4.93 Methods In this observational study, we included patients presenting with STE-ACS undergoing primary percutaneous coronary intervention (PCI).
Cardiovasculardisease, cancer and dementia account for 60% of all deaths in the US. And less diabetes means less of a driver of the three main leading causes of death - cardiovasculardisease, cancer and dementia. In most developed countries as of today, NCDs account for 89% of all deaths. These are NCD’s.
The study, “Comprehensive Cardiovascular Risk Factor Control with a Mobile Health Cardiovascular Risk Self-Management Program,” highlights the potential use of digital health technology in the comprehensive control of risk factors for cardiovasculardisease (CVD), the leading cause of death and disability in the United States.
Background:GLP-1 receptor agonists (GLP1RA) agonists have been shown to reduce cardiovascular events in patients with type 2 diabetes (T2D) and atherosclerotic cardiovasculardisease (ASCVD). Compared to the control group, the GLP1RA cohort had a higher baseline risk profile (BMI: 35.1 [SD Hispanic, 9.6% Asian, and 4.6%
It is currently unknown if these associations are confounded by pleiotropic effects of the instrumental variables (IV) on cardiovasculardisease (CVD) risk factors, such as low-density lipoprotein cholesterol (LDL), diastolic blood pressure (DBP), and body mass index (BMI). 0.96]), or BMI (TSAT: 1.18 [1.04-1.34];
Background High pulse pressure (PP) and aortic root diameter (AoD) are hallmarks of arterial stiffness or vascular aging and they are considered as risk factors for age-related cardiovasculardisease, including heart failure (HF). However, the relationship between PP and AoD in patients with heart failure (HF) is uncertain.
For this reason, the practice guidelines for treating obesity recommend screening adults for overweight and obesity using BMI, diagnosing and establishing treatment targets based on their weight-related complications, as well as using pharmacotherapy and surgery for appropriate patients.
Patients were categorized into a metabolically healthy obese MHO+ve cohort, BMI> 30, and MHO-ve cohort, BMI<30. Trends, demographics, comorbidities, and outcomes were then compared between the two cohorts.Results:Overall Prevalence of stroke was higher in the MHO-ve cohort (2.4%
BMI, body mass index; CV, cardiovascular; CVD, cardiovasculardisease; HELLP, haemolysis, elevated liver enzymes, low platelet count. Abstract During pregnancy, the maternal cardiovascular (CV) system undergoes major haemodynamic alterations ensuring adequate placental perfusion and a healthy pregnancy course.
A, Normal axillary lymph nodes measuring milla1cf Fri, 05/10/2024 - 08:12 May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting , fat-enlarged axillary nodes on screening mammograms can predict high cardiovasculardisease (CVD) risk, Type 2 diabetes (T2DM), and hypertension (HTN).
Background:Hypertension (HTN) is a major risk factor for cardiovasculardisease (CVD) and is the leading cause of morbidity and mortality globally, with a rise in prevalence in low and middle-income countries (LMIC). Median BMI was 27.6 Circulation, Volume 150, Issue Suppl_1 , Page A4146960-A4146960, November 12, 2024.
were hypertensives, and 8 factors, including diabetes, age ≥65 years, higher waist circumference, (BMI) ≥30 kg/m2, lack of formal education, living in urban residence, family history of cardiovasculardiseases, and dyslipidemia use were associated with hypertension.
BMI, body mass index; GLS, global longitudinal strain; LASct, left atrial contractile strain. However, the association of EAT thickness with the development of cardiac dysfunction in subjects with severe obesity without known cardiovasculardisease is unclear.
Background:Racial disparities have been well described in cardiovasculardisease. Stroke, Volume 56, Issue Suppl_1 , Page AWP294-AWP294, February 1, 2025. Patients were categorized into two groups, one with Black or African American and another with White race patients. Both groups were followed for 12 months.
Participants with LVI were significantly older, male, Black, had higher BMI, and lower HDL. There was no significant difference in history of cardiovasculardisease events (6% versus 4%, p=0.143). Participants with LVI were more likely to have diabetes, tobacco use, and atrial fibrillation (24% versus 14%, p<0.001).
Introduction:Peak oxygen uptake (VO2peak), standardized to total body mass (ml/kg/min) is a predictor of morbidity and mortality in cardiovasculardisease patients. years, BMI of 30.3±5.7, Circulation, Volume 150, Issue Suppl_1 , Page A4147807-A4147807, November 12, 2024. Improvement in VO2peak was defined as >% increase.
A healthy lifestyle, in this instance, is defined by a combination of: BMI Nutrition Smoking Status Activity Levels Blood Pressure Diabetes Status Cholesterol Levels All of which are highly modifiable. An elevated Lp(a) does increase the risk of early cardiovasculardisease, but that risk is not set in stone. Atherosclerosis.
Share JUPITER In 2008 a landmark paper was published showing that in people without cardiovasculardisease and relatively normal LDL-cholesterol (<3.4 mmol/l or 130 mg/dl), the use of rosuvastatin 20mg significantly reduced the likelihood of major cardiovascular events 1. What To Do?
But resistance training hasn’t been the focus when it comes to improving cardiovascular health and preventing/reversing cardiovasculardiseases (CVDs) — that honor goes to aerobic exercise training, for which the cardiovascular benefits are well-established and vast. The answer is yes.
But resistance training hasn’t been the focus when it comes to improving cardiovascular health and preventing/reversing cardiovasculardiseases (CVDs) — that honor goes to aerobic exercise training, for which the cardiovascular benefits are well-established and vast. The answer is yes.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content